examined extensively, with the angiotensin I converting Background. To determine the relationship between enzyme (ACE) gene being the favourite candidate gene DNA polymorphisms in the angiotensin I converting for nephropathy [5,6 ]. This has occurred for several enzyme (ACE) gene, serum ACE activity and the risk reasons. First, it was reported a long time ago that of diabetic nephropathy.
Introduction
13-26 encode for the carboxyl domain. Several different DNA polymorphisms have been identified in this Only a subset of insulin-dependent diabetes mellitus gene [10, 19, 20] . A frequent insertion/deletion (I/D) (IDDM ) patients (about 30%) is susceptible to diabetic polymorphism, located in intron 16 has been the one nephropathy [1] , and familial clustering of this com-most studied [10] . The D allele is associated with plication points to genetic factors as the determinants higher plasma levels of ACE than the I allele, and the of susceptibility [2] [3] [4] . So far, genes encoding for D allele also seems to be associated with increased proteins of the renin-angiotensin system have been myocardial infarction risk in diabetic and non-diabetic individuals [10, [21] [22] [23] . It is not clear, however, that populations, the association of the D allele with uria, and values Á300 mg/24 h were considered overt promyocardial infarction has not been confirmed [25] .
teinuria. Individuals were considered cases if the AER was
The role of the I/D polymorphism at the ACE gene Á30 mg/24 h in at least two of the three 24-h collections; all has also been evaluated in the development of kidney others were considered as controls. diseases. The presence of the D allele predisposes to progression of IgA nephropathy [26, 27] , but findings Determination of serum ACE activity with regard to diabetic nephropathy have been contradictory. Whereas Marre et al. [11, 12] reported that the Blood samples were collected in non-heparinized glass tubes I/D polymorphism was associated with the developand centrifuged at 2000 g for 10 min at 4°C. Serum samples ment of diabetic nephropathy, several other studies were frozen and assayed within 2 weeks. Serum ACE activity did not confirm this finding [28, 29] . In our research in was assayed by a radiometric method using [3H ]hippurylBoston, while we found an effect of sequence differ-glycyl-glycine as substrate, as described previously [9] . ences at the ACE locus on the risk of diabetic nephro-Briefly, serum samples (10 ml ) were incubated with 800 nmol pathy, the effect was associated with a polymorphism substrate (25 000 c.p.m., 234.6 mg) for 60 min at 37°C in in intron 7 of the gene rather than the I/D in intron HEPES buffer (0.05 mol/l, pH 8.0) in a final volume of 0.1 ml. The reaction was terminated with 1.0 ml of HCl (0.1 16 [30] . mol/l ); the medium was extracted with 1.5 ml ethyl acetate,
The present study was undertaken to study the centrifuged and the radiolabelled hippuric acid present in the relationship between polymorphisms in the ACE gene organic phase was counted by liquid scintillation specin a Jewish population of IDDM patients and to trometry. ACE activity was expressed as nmol/ml/min. examine whether the association between the specific Interassay CV of 6.1% and 4.2% were obtained for serum polymorphisms in the ACE gene and diabetic nephro-activity of 88 and 184 nmol/ml/min, respectively (n=15), pathy can be accounted for by elevated serum ACE and 5% for intra-assay CV. activities.
Seven patients who had nephropathy and were taking an ACE inhibitor were excluded from the statistical analyses related to ACE activity and blood pressure.
Research design and methods

DNA analysis Study population
DNA was extracted from leukocytes by the phenol-chloroPatients selected for this study included IDDM patients form technique according to standard protocols. Each patient attending the outpatient clinic at the Rabin Medical Centre, had genotypes determined at two loci of the ACE gene one Beilinson Campus, a tertiary referral centre in Petach Tikwa, in the intron 7 (amino domain) and the other in the intron Israel. This group of patients includes some of the patients 16 (carboxyl domain). with IDDM described previously [31] . For the present study A DdeI Polymorphism in intron 7 of the ACE gene was only patients with at least 10 years duration of IDDM were first identified by us as a three allele system (+,-,=) with selected. The study protocol was approved by the Human the denaturing gradient gel electrophoresis (DGGE ) blotting Subjects Committee at the Rabin Medical Centre.
technique [33] . Molecular characterization demonstrated that an A to G substitution in intron 7 of the '+' and '=' alleles gives them a PstI restriction site which is absent in the '-'
Patient examination
allele [26 ] . Therefore, the three allele DdeI polymorphism can be reduced to a two allele system that can be genotyped Each patient had a physical examination performed that with a PCR-based protocol. Flanking primers conincluded height, weight and blood pressure measurements. taining DNA sequences from intron 7 and exon 8 of A standardized questionnaire was used to obtain the medical the gene (5∞-CTCGGCTTGGGACTTCTA-3∞, upstream; history and demographic information. In addition retinopa-5-∞AGAGCTGGTCCATCGTGA-3∞, downstream) produce thy status was assessed by reviewing medical records. 800 bp fragments which, after PstI digestion, permit recogniProliferative retinopathy was diagnosed if a patient had laser tion of two alleles '+' (which includes the minor DdeI allele treatment or had proliferative retinopathy diagnosed by a '=' with the DdeI '+' allele) and '-'. After genotyping half retinal specialist. A blood sample was drawn for biochemical of the PstI '+' patients by DGGE to recognize the DdeI determinations and for isolation of DNA. '=' allele, the distinction was found not to be informative (data not shown), so this analysis is based only on the PstI polymorphism.
Determination of the albumin excretion rate (AER)
The PCR mixture (total volume of 50 ml ) contained 100 ng of genomic DNA together with 0.25 mM of each primer, The albumin excretion rate was determined in three 24-h urine collections performed at least 1 month apart. The urine 2.0 mM MgCl 2 , 5 ml 10×PCR buffer (GeneAmp PCR Core Reagents, Perkin Elmer, Roche), 0.2 mM of each dNTP, and samples were stored in polystyrene tubes at 4°C and assayed within 1 week. Urinary albumin was determined by RIA as 1.25 units of AmpliTaq DNA polymerase (Perkin Elmer, Roche). The PCR mixture was denatured at 94°C for 1 min previously described [32] . Human albumin antibodies were purchased from Bioyeda (Rehovot, Israel ). Human serum followed by annealing at 58°C for 1 min and extension at 72°C for 1.5 min. Amplification was carried out for 30 cycles albumin was obtained from Sigma (Holon, Israel ). 125I-Labelled human albumin (specific activity 10 mCi/mg) was followed by a final extension period of 10 min. The PCR amplified fragments were digested with PstI (New England purchased from the Radiochemical Centre (Negev, Israel ).
Measurements of the AER were classified into three cat-Biolabs, Beverly, MA) and electrophoresed on a 1.5% agarose gel stained with ethidium bromide. The '-' allele was egories: values <30 mg/24 h were considered normal, values The distribution of genotypes and alleles were compared between cases and controls using x2 tests. The association between genotypes and diabetic nephropathy was evaluated aIn the control group, the genotype distribution is consistent with by computing odds ratios (ORs) and 95% confidence intervals Hardy-Weinberg equilibrium. The x2 for departure from equilibrium was 1.39 (1 d.f., P=0.24). In the group of cases, the x2 for departure [35] . pathy status.
Since differences in the distribution of alleles and genotypes among study groups could result from unrecognized popula-the other genotypes (odds ratio 2.3, 95% CI: 1.2-4.5). tion stratification the ethnic origin of study patients was This pattern of association was similar in Ashkenazi defined as previously described [31] . In the analysis, the and non-Ashkenazi patients (odds ratios 2.1 and 2.6, distributions of the I/D or PstI polymorphisms in the study respectively). While the association resulted in a higher Table 1 . The groups had similar distribu-morphism in the ACE gene differed only slightly ( Table 3 ). The group of cases had a deficiency of tions according to sex, age at onset of IDDM, diabetes duration, and ethnic origin (proportion Ashkenazi). heterozygotes and an excess of homozygotes in comparison with controls, but these differences were In comparison with controls, the group of cases had significantly higher means for the albumin excretion not statistically significant ( x2=1.532, 2 d.f. n.s.).
Moreover, the two groups had almost identical frerate, mean blood pressure, ACE activity and proportion of patients with proliferative retinopathy. In the quencies of the D allele (63.5% and 63.6%). ACE activity in serum was examined according to following analysis, the associations between ACE gene polymorphisms in intron 7 (PstI ) and in intron 16 (I/D) genotype at each of these loci. Activity was significantly higher in patients with nephropathy than in those and diabetic nephropathy are examined separately.
For the PstI polymorphism, the genotype distribu-without renal complications (Table 1) . Even after adjusting for this difference between groups with tions in cases and controls were significantly different ( x2=7.153, 2 d.f. P=0.028) ( Table 2) . The difference ANOVA, significant variation was also found according to genotype ( Table 4) . ACE activity was highest was due to an excess of PstI '+/+' homozygotes, implying a risk of nephropathy 2.3 times higher than in patients homozygous for the PstI '-/-' and lowest Table 3 . Distribution of I/D genotypes and alleles in the study groups pathy and the PstI polymorphism in intron 7 of the ACE gene, which was described by us previously Controls Cases [30, 33] . Interestingly, IDDM patients in the current Alleles of the PstI and I/D polymorphism are in linkage disequilibrium (data not shown). Almost all of aIn the control group, the genotype distribution is consistent with the '-' alleles of the PstI polymorphism in intron 7 are Hardy-Weinberg equilibrium. The x2 for departure from equilibrium on chromosomes with the deletion in intron 16, while the '+' alleles of the PstI polymorphism are coupled Table 4 . ACE activity according PstI and I/D genotypes in the with an insertion allele, while the remaining third are study groups coupled with the deletion allele in intron 16. The small sample size does not permit any conclusion about ACE activity (nmol/ml/min) whether there is any differences in the risk of diabetic nephropathy associated with the latter two haplotypes.
Controls Cases
Since the PstI '+' allele is located in an intron [33] , it is presumably a marker of susceptibility rather than as well as other substrates. While the putative disease-causing polymorphism/ for those '+/+', with heterozygotes having inter-mutation may be present in the promoter or regulatory mediate values (ANOVA F=3.53, P=0.03). The parts of introns and influence expression of the ACE higher ACE activity among cases persisted when the gene and levels of the enzyme in the cells as well as in comparison was stratified according to PstI genotype serum, this possibility is not supported by our findings. (F=11.14, P=0.001). A similar pattern was seen for Homozygotes for the PstI '+' allele were at high risk the association between ACE activity and the I/D of diabetic nephropathy and had lower serum ACE polymorphism. ACE activity was lowest in patients activity than other genotypes. On the other hand, homozygous for I/I, highest in D/D homozygotes and homozygotes for the insertion allele had similarly low intermediate in heterozygotes (ANOVA F=6.54, P= serum levels of ACE but were not at particularly high 0.0019). These differences among genotypes, however, risk of diabetic nephropathy. This implies that the could not account for the higher ACE activity in cases. putative nephropathy-causing DNA sequence differThe difference in the ACE activity between cases and ence/mutation in the ACE gene must influence some controls was consistent across genotypes (ANOVA aspect of the biology of ACE other than its serum F=11.55, P=0.0009). When blood pressure was ana-activity. lyzed in the same way as ACE activity, significantly
The findings of the present study agree with our higher diastolic and systolic blood pressures were found previous report in which we showed that the DdeI '=' in patients with nephropathy than in those without. allele (in the current study included as part of the PstI However, blood pressure was not influenced by PstI '+' allele) was associated with increased risk of diabetic or I/D genotypes (data not shown).
nephropathy [30] . The extra risk of nephropathy associated with these alleles, however, was moderate in Discussion both studies. This indicates, perhaps, that the risk of nephropathy attributable to genetic variability at the ACE locus is relatively small. The small attributable In this study of Jewish IDDM patients, we found an association between prevalence of diabetic nephro-risk, as well as the undefined nature of the putative factors determine the development of diabetic nephropathy in polymorphism/mutations, presumably contributed to patients with IDDM. Diabetologia 1996; 39: 940-945 the discrepancies among studies reported so far 5. Schmidt S, Ritz E. Genetics of the renin-angiotensin system and [11, 12, [28] [29] [30] . If the degree of linkage disequilibrium renal disease: a progress report. 
